<DOC>
	<DOCNO>NCT00442104</DOCNO>
	<brief_summary>To allow open-label extension patient complete Protocol 1042-0500</brief_summary>
	<brief_title>Open-label Extension Protocol 1042-0500</brief_title>
	<detailed_description>Patient complete scheduled clinical study visit double blind , control trial ( Protocol 1042-0500 ) deem eligible ( response treatment ) Investigator . Male female , diagnosis IS video EEG ( vEEG ) record confirm diagnosis . There total 14 visit 99 ( +or-1 ) week . A 24-hr vEEG require subject spasm-free 24-hrs .</detailed_description>
	<mesh_term>Spasm</mesh_term>
	<mesh_term>Spasms , Infantile</mesh_term>
	<mesh_term>Pregnanolone</mesh_term>
	<criteria>Have complete schedule clinical study visit previous Protocol 1042 0500 deem eligible ( SAEs think drug relate response treatment ) Investigator . Be diagnose IS regardless etiology . Diagnostic Criteria : Seizures consist single repetitive short muscular contraction lead flexion extension . Spasms may characterize tonic myoclonic contraction , may occur singly cluster , typically occur bilaterally symmetrically . The EEG pattern must consistent diagnosis IS ( hypsarrhythmia , modify hypsarrhythmia , multifocal spike wave discharge , etc ) . Have 24 hour vEEG record confirm diagnosis IS . Have magnetic resonance imaging ( MRI ) perform determine possible cause IS . Have previously treat 3 AEDs few . Have parent/guardian properly inform nature potential risk benefit clinical study , willing capable comply clinical study procedure , give informed consent write prior enter clinical study . Current treatment 2 concomitant AEDs . Have active CNS infection , demyelinate disease , degenerative neurological disease , CNS disease deem progressive ( exception tuberous sclerosis ) evaluate brain MRI . Have disease condition ( medical surgical ) Screening might compromise hematologic , cardiovascular , pulmonary , renal , GI , hepatic system ; condition might interfere absorption , distribution , metabolism , excretion investigational product , would place subject increase risk . Aspartate transaminase ( AST ) , alanine transaminase ( ALT ) , total bilirubin great 4 time upper limit laboratory normal clinical laboratory value deem clinically significant Investigator . History recurrent status epilepticus . Have expose investigational drug within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>4 Months</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>infantile spasm</keyword>
	<keyword>anticonvulsant</keyword>
	<keyword>pediatric epilepsy</keyword>
	<keyword>West Syndrome</keyword>
	<keyword>epileptic spasm</keyword>
</DOC>